eSensor Warfarin Sensitivity Saliva Test
Cytochrome P450 2c9 (Cyp450 2c9) Drug Metabolizing Enzyme Genotyping System. 510(k) K152612, from Genmark Diagnostics, Incorporated (Carlsbad, CA). Product code ODW, class 2.
As of Nov 20, 2026, K152612 is an FDA 510(k) held by Genmark Diagnostics, Incorporated, substantially equivalent on May 26, 2016 after 255 days, with no recalls tied to it in FDA's recall database.
- Review time: 255 days
- Recalls: 0
The eSensor® Warfarin Sensitivity Saliva Test is an in vitro diagnostic for the detection and genotyping of the *2 and *3 alleles of the cytochrome P450 (CYP450) 2C9 gene locus and the Vitamin K epoxide reductase C1 (VKORC1) gene promoter polymorphism (-1639G>A) from genomic DNA extracted from human saliva samples collected using the Oragene®•Dx and ORAcollect®•Dx devices, as an aid in the…
- Esensor Warfarin Sensitivity Saliva TestK110786 · GenMark Diagnostics, Inc. · Dec 2, 2011
- ORAcollect.DxK152464 · DNA Genotek, Inc. · May 26, 2016
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Sep 14, 2015
- Review panel
- Clinical Toxicology
- Regulation
- 21 CFR 862.3360
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files